3-10036271-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018115.3(FANCD2):​c.439-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,597,844 control chromosomes in the GnomAD database, including 23,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3423 hom., cov: 29)
Exomes 𝑓: 0.16 ( 20510 hom. )

Consequence

FANCD2
NM_001018115.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.723

Publications

19 publications found
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
FANCD2 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group D2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-10036271-A-G is Benign according to our data. Variant chr3-10036271-A-G is described in ClinVar as Benign. ClinVar VariationId is 257083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.315 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCD2NM_001018115.3 linkc.439-16A>G intron_variant Intron 6 of 43 ENST00000675286.1 NP_001018125.1 Q9BXW9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCD2ENST00000675286.1 linkc.439-16A>G intron_variant Intron 6 of 43 NM_001018115.3 ENSP00000502379.1 Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29682
AN:
151020
Hom.:
3419
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.320
Gnomad AMI
AF:
0.268
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.0655
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.161
Gnomad OTH
AF:
0.170
GnomAD2 exomes
AF:
0.162
AC:
40657
AN:
251320
AF XY:
0.161
show subpopulations
Gnomad AFR exome
AF:
0.336
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.159
Gnomad EAS exome
AF:
0.0657
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.159
Gnomad OTH exome
AF:
0.158
GnomAD4 exome
AF:
0.163
AC:
236401
AN:
1446706
Hom.:
20510
Cov.:
29
AF XY:
0.163
AC XY:
117783
AN XY:
720572
show subpopulations
African (AFR)
AF:
0.330
AC:
10890
AN:
32988
American (AMR)
AF:
0.158
AC:
7031
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
4053
AN:
26018
East Asian (EAS)
AF:
0.0566
AC:
2244
AN:
39630
South Asian (SAS)
AF:
0.179
AC:
15362
AN:
85934
European-Finnish (FIN)
AF:
0.123
AC:
6564
AN:
53210
Middle Eastern (MID)
AF:
0.163
AC:
930
AN:
5720
European-Non Finnish (NFE)
AF:
0.163
AC:
179478
AN:
1098726
Other (OTH)
AF:
0.165
AC:
9849
AN:
59848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
9318
18636
27954
37272
46590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6422
12844
19266
25688
32110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.197
AC:
29707
AN:
151138
Hom.:
3423
Cov.:
29
AF XY:
0.191
AC XY:
14124
AN XY:
73832
show subpopulations
African (AFR)
AF:
0.320
AC:
13125
AN:
41032
American (AMR)
AF:
0.144
AC:
2189
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
522
AN:
3462
East Asian (EAS)
AF:
0.0654
AC:
338
AN:
5166
South Asian (SAS)
AF:
0.160
AC:
765
AN:
4786
European-Finnish (FIN)
AF:
0.115
AC:
1202
AN:
10438
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.161
AC:
10927
AN:
67770
Other (OTH)
AF:
0.170
AC:
358
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
1001
2002
3002
4003
5004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.180
Hom.:
618
Bravo
AF:
0.208
Asia WGS
AF:
0.115
AC:
403
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group D2 Benign:3
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 11, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.0080
DANN
Benign
0.58
PhyloP100
-0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17032278; hg19: chr3-10077955; API